ID   APBA1_RAT               Reviewed;         839 AA.
AC   O35430;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   24-JUL-2024, entry version 154.
DE   RecName: Full=Amyloid-beta A4 precursor protein-binding family A member 1;
DE   AltName: Full=Adapter protein X11alpha;
DE   AltName: Full=Neuron-specific X11 protein;
DE   AltName: Full=Neuronal Munc18-1-interacting protein 1;
DE            Short=Mint-1;
GN   Name=Apba1; Synonyms=Mint1, X11;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9395480; DOI=10.1074/jbc.272.50.31459;
RA   Okamoto M., Suedhof T.C.;
RT   "Mints, Munc18-interacting proteins in synaptic vesicle exocytosis.";
RL   J. Biol. Chem. 272:31459-31464(1997).
RN   [2]
RP   INTERACTION WITH CASK AND LIN7.
RC   TISSUE=Testis;
RX   PubMed=9753324; DOI=10.1016/s0092-8674(00)81736-5;
RA   Butz S., Okamoto M., Suedhof T.C.;
RT   "A tripartite protein complex with the potential to couple synaptic vesicle
RT   exocytosis to cell adhesion in brain.";
RL   Cell 94:773-782(1998).
RN   [3]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH FSBP.
RX   PubMed=20531236; DOI=10.1097/wnr.0b013e32833bfca0;
RA   Lau K.F., Perkinton M.S., Rodriguez L., McLoughlin D.M., Miller C.C.;
RT   "An X11alpha/FSBP complex represses transcription of the GSK3beta gene
RT   promoter.";
RL   NeuroReport 21:761-766(2010).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-247; SER-249;
RP   SER-264; SER-286; SER-314 AND SER-570, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 453-643, AUTOINHIBITORY DOMAIN,
RP   MUTAGENESIS OF TYR-633, AND INTERACTION WITH APP.
RX   PubMed=22355143; DOI=10.1073/pnas.1119075109;
RA   Matos M.F., Xu Y., Dulubova I., Otwinowski Z., Richardson J.M.,
RA   Tomchick D.R., Rizo J., Ho A.;
RT   "Autoinhibition of Mint1 adaptor protein regulates amyloid precursor
RT   protein binding and processing.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:3802-3807(2012).
CC   -!- FUNCTION: Putative function in synaptic vesicle exocytosis by binding
CC       to Munc18-1, an essential component of the synaptic vesicle exocytotic
CC       machinery. May modulate processing of the amyloid-beta precursor
CC       protein (APP) and hence formation of APP-beta.
CC   -!- SUBUNIT: Part of a multimeric complex containing STXBP1 and STX1A.
CC       Interacts with STXBP1 (By similarity). Component of the brain-specific
CC       heterotrimeric complex (LIN-10-LIN-2-LIN-7 complex) composed of at
CC       least APBA1, CASK, and LIN7, which associates with the motor protein
CC       KIF17 to transport vesicles along microtubules (By similarity). Within
CC       the complex, interacts (via PDZ domain) with the motor protein KIF17;
CC       the interaction is direct and is required for association of KIF17 with
CC       the cargo that is to be transported (By similarity). Binds to the
CC       cytoplasmic domain of amyloid protein (APP) (By similarity). Interacts
CC       (via PDZ 1 and 2 domains) with FSPB (By similarity). Isoform 2
CC       interacts (via its truncated PID domain) with active, GTP-bound RAB6A
CC       and RAB6B (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:B2RUJ5}.
CC   -!- INTERACTION:
CC       O35430; P32851: Stx1a; NbExp=3; IntAct=EBI-704760, EBI-539720;
CC       O35430; P61765: Stxbp1; NbExp=5; IntAct=EBI-704760, EBI-1029097;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cytoplasm, perinuclear
CC       region {ECO:0000250}. Nucleus {ECO:0000269|PubMed:20531236}. Note=Only
CC       a small proportion of the protein is nuclear.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Golgi apparatus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O35430-1; Sequence=Displayed;
CC       Name=2; Synonyms=Mint1_826;
CC         IsoId=O35430-2; Sequence=VSP_053520;
CC   -!- TISSUE SPECIFICITY: Brain. Detected in the cerebellum, hippocampus,
CC       olfactory system, piriform and entorhinal cortex, supraoptic nucleus of
CC       the hypothalamus, substantia nigra, and other mesencephalic areas.
CC   -!- DOMAIN: Composed of an N-terminal domain that binds Munc18-1 and LIN-
CC       2/CASK, a middle phosphotyrosine-binding domain (PID/PTB) that mediates
CC       binding with the cytoplasmic domain of the amyloid-beta precursor
CC       protein, and two C-terminal PDZ domains thought to attach proteins to
CC       the plasma membrane. {ECO:0000250}.
CC   -!- DOMAIN: The autoinhibitory helix linker occludes the APP binding site.
CC   -!- DOMAIN: The PID domain, truncated by 11 amino acids, as observed in
CC       isoform 2, but not full-length, mediates the interaction with RAB6A.
CC       {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform 2]: This isoform interacts with RAB6 GTPases.
CC       {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF029105; AAC05303.1; -; mRNA.
DR   RefSeq; NP_113967.1; NM_031779.2.
DR   PDB; 4DBB; X-ray; 1.90 A; A=453-643.
DR   PDB; 6KMH; X-ray; 2.40 A; C/D=338-397.
DR   PDB; 7XSJ; X-ray; 3.20 A; C=227-303.
DR   PDBsum; 4DBB; -.
DR   PDBsum; 6KMH; -.
DR   PDBsum; 7XSJ; -.
DR   AlphaFoldDB; O35430; -.
DR   BMRB; O35430; -.
DR   SMR; O35430; -.
DR   BioGRID; 249774; 7.
DR   CORUM; O35430; -.
DR   ELM; O35430; -.
DR   IntAct; O35430; 3.
DR   MINT; O35430; -.
DR   STRING; 10116.ENSRNOP00000020123; -.
DR   BindingDB; O35430; -.
DR   CarbonylDB; O35430; -.
DR   iPTMnet; O35430; -.
DR   PhosphoSitePlus; O35430; -.
DR   PaxDb; 10116-ENSRNOP00000020123; -.
DR   PeptideAtlas; O35430; -.
DR   Ensembl; ENSRNOT00055054130; ENSRNOP00055044768; ENSRNOG00055031190. [O35430-1]
DR   Ensembl; ENSRNOT00060036812; ENSRNOP00060030323; ENSRNOG00060021137. [O35430-1]
DR   Ensembl; ENSRNOT00065042702; ENSRNOP00065034956; ENSRNOG00065024825. [O35430-1]
DR   GeneID; 83589; -.
DR   KEGG; rno:83589; -.
DR   UCSC; RGD:620844; rat. [O35430-1]
DR   AGR; RGD:620844; -.
DR   CTD; 320; -.
DR   RGD; 620844; Apba1.
DR   eggNOG; KOG3605; Eukaryota.
DR   InParanoid; O35430; -.
DR   OrthoDB; 2881953at2759; -.
DR   PhylomeDB; O35430; -.
DR   Reactome; R-RNO-212676; Dopamine Neurotransmitter Release Cycle.
DR   EvolutionaryTrace; O35430; -.
DR   PRO; PR:O35430; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043197; C:dendritic spine; IDA:CACAO.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0048787; C:presynaptic active zone membrane; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0001540; F:amyloid-beta binding; IPI:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:RGD.
DR   GO; GO:0005546; F:phosphatidylinositol-4,5-bisphosphate binding; IDA:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0014051; P:gamma-aminobutyric acid secretion; ISO:RGD.
DR   GO; GO:0014047; P:glutamate secretion; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0006886; P:intracellular protein transport; ISO:RGD.
DR   GO; GO:0007626; P:locomotory behavior; ISO:RGD.
DR   GO; GO:0035264; P:multicellular organism growth; ISO:RGD.
DR   GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0016079; P:synaptic vesicle exocytosis; TAS:RGD.
DR   CDD; cd22578; Mint1_CID; 1.
DR   CDD; cd00992; PDZ_signaling; 2.
DR   CDD; cd01208; PTB_X11; 1.
DR   Gene3D; 2.30.42.10; -; 2.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   InterPro; IPR051230; APP-Binding.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR006020; PTB/PI_dom.
DR   PANTHER; PTHR12345:SF14; AMYLOID-BETA A4 PRECURSOR PROTEIN-BINDING FAMILY A MEMBER 1; 1.
DR   PANTHER; PTHR12345; SYNTENIN RELATED; 1.
DR   Pfam; PF00595; PDZ; 2.
DR   Pfam; PF00640; PID; 1.
DR   SMART; SM00228; PDZ; 2.
DR   SMART; SM00462; PTB; 1.
DR   SUPFAM; SSF50156; PDZ domain-like; 2.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   PROSITE; PS50106; PDZ; 2.
DR   PROSITE; PS01179; PID; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Golgi apparatus; Nucleus;
KW   Phosphoprotein; Protein transport; Reference proteome; Repeat; Transport.
FT   CHAIN           1..839
FT                   /note="Amyloid-beta A4 precursor protein-binding family A
FT                   member 1"
FT                   /id="PRO_0000064615"
FT   DOMAIN          459..645
FT                   /note="PID"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00148"
FT   DOMAIN          658..744
FT                   /note="PDZ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          749..824
FT                   /note="PDZ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          1..118
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          227..315
FT                   /note="Munc-18-1 binding"
FT   REGION          235..346
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          362..437
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          375..438
FT                   /note="LIN-2/CASK binding"
FT   REGION          628..643
FT                   /note="Autoinhibitory helix linker"
FT   COMPBIAS        101..118
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        235..275
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        402..416
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        423..437
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         79
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:B2RUJ5"
FT   MOD_RES         243
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         247
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         249
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         264
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         281
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:B2RUJ5"
FT   MOD_RES         286
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         306
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q02410"
FT   MOD_RES         314
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         369
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:B2RUJ5"
FT   MOD_RES         372
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q02410"
FT   MOD_RES         403
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:B2RUJ5"
FT   MOD_RES         405
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:B2RUJ5"
FT   MOD_RES         410
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:B2RUJ5"
FT   MOD_RES         570
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         497..507
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_053520"
FT   MUTAGEN         633
FT                   /note="Y->E: Enhanced APP binding and amyloid-beta
FT                   production."
FT                   /evidence="ECO:0000269|PubMed:22355143"
FT   MUTAGEN         633
FT                   /note="Y->F: No change in APP binding."
FT                   /evidence="ECO:0000269|PubMed:22355143"
FT   HELIX           271..282
FT                   /evidence="ECO:0007829|PDB:7XSJ"
FT   HELIX           342..364
FT                   /evidence="ECO:0007829|PDB:6KMH"
FT   STRAND          460..477
FT                   /evidence="ECO:0007829|PDB:4DBB"
FT   HELIX           481..493
FT                   /evidence="ECO:0007829|PDB:4DBB"
FT   STRAND          517..532
FT                   /evidence="ECO:0007829|PDB:4DBB"
FT   TURN            533..535
FT                   /evidence="ECO:0007829|PDB:4DBB"
FT   STRAND          538..543
FT                   /evidence="ECO:0007829|PDB:4DBB"
FT   HELIX           544..546
FT                   /evidence="ECO:0007829|PDB:4DBB"
FT   STRAND          547..553
FT                   /evidence="ECO:0007829|PDB:4DBB"
FT   STRAND          556..563
FT                   /evidence="ECO:0007829|PDB:4DBB"
FT   STRAND          587..595
FT                   /evidence="ECO:0007829|PDB:4DBB"
FT   HELIX           599..614
FT                   /evidence="ECO:0007829|PDB:4DBB"
FT   HELIX           615..617
FT                   /evidence="ECO:0007829|PDB:4DBB"
FT   HELIX           625..627
FT                   /evidence="ECO:0007829|PDB:4DBB"
FT   HELIX           630..639
FT                   /evidence="ECO:0007829|PDB:4DBB"
SQ   SEQUENCE   839 AA;  92654 MW;  57F6EEA458376CAD CRC64;
     MNHLEGSAEV EVADEAPGGE VNESVEADLE HPEVEEEQQP SPPPPAGHAP EDHRAHPAPP
     PPPPPQEEEE ERGECLARSA STESGFHNHT DTAEGDVLAA ARDGYEAERA QDADDESAYA
     VQYRPEAEEY TEQAEAEHAE AAQRRALPNH LHFHSLEHEE AMNAAYSGYV YTHRLFHRAE
     DEPYAEPYAD YGGLQEHVYE EIGDAPELEA RDGLRLYERE RDEAAAYRQE ALGARLHHYD
     ERSDGESDSP EKEAEFAPYP RMDSYEQEED IDQIVAEVKQ SMSSQSLDKA AEDMPEAEQD
     LERAPTPGGG HPDSPGLPAP AGQQQRVVGT PGGSEVGQRY SKEKRDAISL AIKDIKEAIE
     EVKTRTIRSP YTPDEPKEPI WVMRQDISPT RDCDDQRPVD GDSPSPGSSS PLGAESSITP
     LHPGDPTEAS TNKESRKSLA SFPTYVEVPG PCDPEDLIDG IIFAANYLGS TQLLSDKTPS
     KNVRMMQAQE AVSRIKTAQK LAKSRKKAPE GESQPMTEVD LFISTQRIKV LNADTQEPMM
     DHPLRTISYI ADIGNIVVLM ARRRMPRSNS QENVEASHPS QDAKRQYKMI CHVFESEDAQ
     LIAQSIGQAF SVAYQEFLRA NGINPEDLSQ KEYSDLLNTQ DMYNDDLIHF SKSENCKDVF
     IEKQKGEILG VVIVESGWGS ILPTVIIANM MHGGPAEKSG KLNIGDQIMS INGTSLVGLP
     LSTCQSIIKG LKNQSRVKLN IVRCPPVTTV LIRRPDLRYQ LGFSVQNGII CSLMRGGIAE
     RGGVRVGHRI IEINGQSVVA TPHEKIVHIL SNAVGEIHMK TMPAAMYRLL TAQEQPVYI
//
